Skip to main content
. 2017 Mar 13;9(5):638–654. doi: 10.15252/emmm.201607296

Figure EV2. ∆F4LJ2R VACV retains much of the replication proficiency of wild‐type VACV in bladder cancer cells.

Figure EV2

Growth curves for the indicated VACV mutants or WT VACV. Subconfluent cells were infected at a multiplicity of infection of 0.03 PFU/cell. Cultures were harvested at the indicated times and titered on BSC‐40 cells.
  1. Normal human kidney epithelial cells grown under normal serum conditions (left) and 0.1% FBS (right).
  2. Panel of human bladder cancer cell lines (exception: MB49‐luc, murine urothelial carcinoma) cultured in vitro with 10% FBS.
Data information: Mean ± SEM is shown and data represent at least two independent lysates titered in duplicate.